Clinical Trial Update: Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating landiolol for preventing postoperative atrial fibrillation in patients undergoing cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• LANdiolol (landiolol hydrochloride)

Snippet

Sponsor: Medical University of Vienna | Conditions: Atrial Fibrillation, Postoperative Complications | Phase 3 | Status: UNKNOWN